Page last updated: 2024-09-03

tazobactam and trospectomycin

tazobactam has been researched along with trospectomycin in 1 studies

Compound Research Comparison

Studies (tazobactam)	Trials (tazobactam)	Recent Studies (post-2010) (tazobactam)	Studies (trospectomycin)	Trials (trospectomycin)	Recent Studies (post-2010) (trospectomycin)
1,327	153	694	59	6	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Appelbaum, PC; Jacobs, MR; Spangler, SK	1

Other Studies

1 other study(ies) available for tazobactam and trospectomycin

Article	Year
Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam. The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:2 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Drug Combinations; Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Spectinomycin; Tazobactam; Thienamycins; Virginiamycin	1993

Article

Year

Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.

The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:2

Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Drug Combinations; Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Spectinomycin; Tazobactam; Thienamycins; Virginiamycin

1993